Andrew Allen, Gritstone CEO (Gritstone via website)

Grit­stone con­tin­ues Covid-19 push with deal to de­vel­op 'self-am­pli­fy­ing RNA' vac­cines, as shares con­tin­ue bal­loon­ing

Grit­stone On­col­o­gy has had a big week, and it’s on­ly Wednes­day.

On Tues­day, the biotech re­vealed plans to start clin­i­cal test­ing of an ex­per­i­men­tal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.